Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
Alternative lengthening of telomeres (ALT) is associated with a poor outcome in neuroblastoma. Here, the authors find that ALT is associated with mutated ATRX and/or reduced protein abundance, frequent telomeric repeat loci and heterochromatic telomeric chromatin.
Guardado en:
Autores principales: | Sabine A. Hartlieb, Lina Sieverling, Michal Nadler-Holly, Matthias Ziehm, Umut H. Toprak, Carl Herrmann, Naveed Ishaque, Konstantin Okonechnikov, Moritz Gartlgruber, Young-Gyu Park, Elisa Maria Wecht, Larissa Savelyeva, Kai-Oliver Henrich, Carolina Rosswog, Matthias Fischer, Barbara Hero, David T. W. Jones, Elke Pfaff, Olaf Witt, Stefan M. Pfister, Richard Volckmann, Jan Koster, Katharina Kiesel, Karsten Rippe, Sabine Taschner-Mandl, Peter Ambros, Benedikt Brors, Matthias Selbach, Lars Feuerbach, Frank Westermann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/451b2c4a26e94327b98d615c78ab75da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
por: Lars Feuerbach
Publicado: (2021) -
Enriched sleep environments lengthen lemur sleep duration.
por: Alexander Q Vining, et al.
Publicado: (2021) -
Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: Alexandre de Nonneville, et al.
Publicado: (2021) -
Enriched sleep environments lengthen lemur sleep duration
por: Alexander Q. Vining, et al.
Publicado: (2021) -
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance.
por: Mathurin Dorel, et al.
Publicado: (2021)